补充和MHC模式可以为炎症神经肌肉疾病提供诊断框架
Christopher Nelke1, Simone Schmid2, Felix Kleefeld3
1Department of Neurology, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany.
Acta neuropathologica
|January 12, 2024
概括
主体组织相容性复合体 (MHC) 和免疫组织化学中的补充模式可以帮助诊断罕见的炎症性神经肌肉疾病. 本综述为这些具有挑战性的条件提出了一种简化诊断算法.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 炎症性神经肌肉疾病由于异质性,罕见性和重叠的症状而存在诊断挑战.
- 标准化,具有成本效益的诊断工具至关重要,特别是在资源有限的环境中.
研究的目的:
- 突出主要组织相容性复合体 (MHC) 的诊断实用性,并在免疫组织化学分析中补充模式.
- 为炎症性神经肌肉疾病提出简化的诊断算法,重点关注异常性炎症性肌肉病变.
主要方法:
- 在炎症性肌肉病症中审查MHC和补充特征的基础免疫学原理.
- 在诊断价值方面探索免疫组织化学模式.
主要成果:
- MHC和补充模式为神经肌肉疾病的炎症特征提供了宝贵的见解.
- 基于有限染色面板的诊断算法可能会简化诊断工作.
结论:
- 对MHC和补充模式的免疫组合化学分析显示,对于诊断炎症性神经肌肉疾病具有前途.
- 需要进一步的大规模研究来验证这些标记物并建立共识诊断协议.
更多相关视频
13:10In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
11.8K
08:41Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
Published on: August 14, 2021
8.6K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
847
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
847
Antigens Involved in Adaptive Immunity
497
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
497
